Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5847774

CNC(=O)C[n+]1ccccc1.[Cl-]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.49
HSP90AA1 P07900 4/20 0.53
POLB P06746 3/20 0.49
KMT2A Q03164 4/20 0.49
ALDH1A1 P00352 2/20 0.49
MAPK1 P28482 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.46
LMNA P02545 1/20 0.45
BACE1 P56817 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8120184 0.98 KMT2A (0.50) HSP90AA1POLBKMT2AALDH1A1MAPK1
Hydrochloric Acid SCHEMBL713375 0.78 HSP90AA1 (0.53) HSP90AA1POLBKMT2AALDH1A1MAPK1
SCHEMBL9579601 0.77 LMNA (0.40) KMT2AACHEMAPTLMNA
SCHEMBL297246 0.76 HSP90AA1 (0.50) HSP90AA1POLBKMT2AALDH1A1MAPK1
SCHEMBL7048071 0.76 HSP90AA1 (0.50) HSP90AA1POLBKMT2AALDH1A1MAPK1
SCHEMBL16674109 0.76 HSP90AA1 (0.59) HSP90AA1POLBKMT2AALDH1A1MAPK1
SCHEMBL13965280 0.75 KMT2A (0.55) HSP90AA1POLBKMT2AALDH1A1MAPK1
Hydrochloric Acid SCHEMBL420325 0.75 KMT2A (0.54) HSP90AA1POLBKMT2AALDH1A1MAPK1
Hydrochloric Acid SCHEMBL5848674 0.74 HSP90AA1 (0.50) HSP90AA1POLBKMT2AALDH1A1MAPK1
Hydrochloric Acid SCHEMBL344009 0.74 KMT2A (0.52) HSP90AA1POLBKMT2AALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7026326-B2 Substituted heterocyclic compounds and methods of use AMGEN INC. (US) 2006-04-11 US disclosed
US-20050038010-A1 Substituted heterocyclic compounds and methods of use AMGEN, INC. 2005-02-17 US disclosed
EP-1506186-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2005-02-16 EP disclosed
WO-2003099808-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2003-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038010-A1 Substituted heterocyclic compounds and methods of use MYLK2, MYLK, MCL1 ACHE 294/4885HSP90AA1 719/4885POLB 2945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.